Daniel Lackland to Evidence-Based Medicine
This is a "connection" page, showing publications Daniel Lackland has written about Evidence-Based Medicine.
Connection Strength
0.673
-
Assessing healthcare professional knowledge, attitudes, and practices on hypertension management. Announcing a new World Hypertension League resource. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):830-832.
Score: 0.469
-
How will the growing threat of resistant hypertension impact the future treatment of high blood pressure? Expert Rev Cardiovasc Ther. 2013 Nov; 11(11):1541-6.
Score: 0.090
-
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 10 23; 138(17):e595-e616.
Score: 0.032
-
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015 May 12; 131(19):e435-70.
Score: 0.025
-
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 05; 311(5):507-20.
Score: 0.023
-
Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative. J Contin Educ Health Prof. 2014; 34(1):25-36.
Score: 0.023
-
A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8.
Score: 0.012